Name of Industry or Sector (Strategic Group)The Pharmaceutical Industry Threat of new entrants Several aspects have been taken into consideration for the threat of new entrants. Firstly, the expenditure of R&D is too costly, especially for the branded prescription drugs. Regarding the pipeline, it takes too long a time for new drugs to move from discovery to market, nearly 12 years. In this situation, the spending on R&D is high due …showed first 75 words of 1429 total…

…showed last 75 words of 1429 total…and Cases, England: Pearson Education Limited, p. 630-650. Others: Humer, Franz B. 'The Pharmaceutical Industry in the Global Economy'. Nov 20, 2002. Oct 26, 2003 < http://mitworld.mit.edu/video/59/>. Smith, Nancy DuVergne (Dec 18, 2002). 'Pharmaceutical Industry balances Profits, Moral Responsibilities'. Oct 26, 2003 <http://web.mit.edu/newsoffice/tt/2002/dec18/humer.html>. Weber, Joseph, Amy Barrett, Michael Mandel and Jeff Laderman (Nov 5, 1998). 'The New Ear of Lifestyle Drugs'. Oct 27, 2003 <http://www.businessweek.com/1998/19/topstory.htm>.